The New Mexico Securities Division has joined a multistate settlement with several financial firms accused of overcharging customers.
Featured
Latest News
People
CDC releases COVID-19 guidance for those with health conditions
- Leonard named new president of the Association for Accessible Medicines
- Best in health care showcased in 2020 We Work for Health Champion Awards
- Grein: Those suffering from COVID-19 receiving experimental treatments
- APRECIA: Kimberly Bone, PharmD, named Aprecia's Vice President of Medical & Clinical Affairs
Innovation
Fifth vaccine set to enter Phase III clinical trials
- Vaccination efforts for frontline health care workers underway following Pfizer vaccine approval
- PTCB: Pharmacy Technician Certification Board (PTCB) Rolls Out Advanced Certification for Experienced Pharmacy Technicians Who Have Comprehensive Knowledge and Skills
- AZD1222 vaccine meets base requirements in efficacy for preventing, treating COVID-19
- endpoint and McCreadie Group Software Integration Reduces Drug Speed to Market and Streamlines Research Pharmacy Workflows
Regulatory
Pediatrician: 'Large corporations are using the 340B program as a cash cow'
- Former FTC director on 340B program: ‘Drug discounts are being captured by corporate hospital systems'
- Researcher on 340B: Physicians 'select patients who require more intensive pharmaceutical treatments after joining the 340B program'
- National Consumers League announces poll showing support for 340B drug pricing reform
- Doctor on Eli Lilly compounding pharmacy lawsuit: 'We are now left with very little options outside the branded medications'
Industry
- Empower Pharmacy CEO on pharmaceutical lobbying pressure: 'A resurgence of compounding is coming'
- Empower Pharmacy challenges Eli Lilly tirzepatide patent before U.S. Patent Trial and Appeal Board
- Monty's Home Medical highlights benefits of tailored compounded medications
- KFF polling finds over half of all adults struggle to afford GLP-1 drugs
Alerts Sign-up